Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Capital Employed (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Return on Capital Employed for 11 consecutive years, with 1.06% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 40.0% year-over-year to 1.06%, compared with a TTM value of 1.06% through Sep 2025, down 40.0%, and an annual FY2024 reading of 0.57%, changed N/A over the prior year.
  • Return on Capital Employed was 1.06% for Q3 2025 at Lisata Therapeutics, down from 0.92% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.36% in Q2 2023 and bottomed at 1.06% in Q3 2025.
  • Average Return on Capital Employed over 3 years is 0.63%, with a median of 0.57% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -15bps in 2024, then plummeted -40bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.5% in 2023, then tumbled by -44bps to 0.72% in 2024, then plummeted by -47bps to 1.06% in 2025.
  • Business Quant data shows Return on Capital Employed for LSTA at 1.06% in Q3 2025, 0.92% in Q2 2025, and 0.77% in Q1 2025.